Dunedin, New Zealand

Tony R Merriman


Average Co-Inventor Count = 13.0

ph-index = 2

Forward Citations = 9(Granted Patents)


Location History:

  • Oxford, GB (2003)
  • Dunedin, NZ (2003 - 2007)

Company Filing History:


Years Active: 2003-2007

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Tony R Merriman: Innovator in Genetic Research

Introduction

Tony R Merriman is a notable inventor based in Dunedin, New Zealand. He has made significant contributions to the field of genetic research, particularly in relation to type 1 diabetes and other autoimmune diseases. With a total of 3 patents, his work has implications for various medical treatments and diagnostics.

Latest Patents

Merriman's latest patents include a method of screening for modulators of LRP5 activity. This invention introduces a novel receptor, LDL-receptor-related protein-5 (LRP-5), along with its encoding nucleic acid. The gene is associated with type 1 diabetes, specifically the IDDM susceptibility gene IDDM4. The invention encompasses nucleic acids, coding sequences, oligonucleotide primers and probes, polypeptides, pharmaceutical compositions, and methods for diagnosis or prognosis. It also provides methods for treating diseases linked to this gene, including autoimmune diseases, glomerulonephritis, and conditions such as osteoporosis and Alzheimer's disease.

Another significant patent involves the LDL-receptor, which introduces the LDL-receptor related protein-3 (LRP-3) and its encoding nucleic acid. Similar to his previous work, this invention is associated with type 1 diabetes and offers various applications in medical treatment and diagnostics.

Career Highlights

Throughout his career, Merriman has worked with esteemed organizations, including the Wellcome Trust Limited, where he served as a trustee. His research has been pivotal in advancing our understanding of genetic factors in diseases.

Collaborations

Merriman has collaborated with notable individuals in the field, including John A Todd and John W Hess. Their combined expertise has contributed to the success of various research initiatives.

Conclusion

Tony R Merriman's innovative work in genetic research has led to significant advancements in understanding and treating autoimmune diseases. His contributions continue to impact the medical field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…